publication venue for
- Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides.. 22. 2019
- Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial.. 20. 2018
- Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?. 18. 2015
- Predictive and prognostic value of LPS-stimulated cytokine secretion in metastatic non-small cell lung cancer.. 15. 2013
- Beam angle selection for intensity-modulated radiotherapy (IMRT) treatment of unresectable pancreatic cancer: are noncoplanar beam angles necessary?. 15. 2013
- Pilot study of feasibility and dosimetric comparison of prone versus supine breast radiotherapy.. 15. 2012
- Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma.. 12. 2010
- Treatment of anal carcinoma in immune-compromised patients.. 11. 2009
- GRP78 and α2-macroglobulin are new promising targets for metastatic castrate-resistant prostate cancer treatment. 2015
- Bevacizumab in advanced cervical cancer. 2014
- Ependymoma in children: molecular considerations and therapeutic insights. 2013
- Role of stereotactic body radiotherapy in the management of primary hepatocellular carcinoma. Rationale, technique and results. 2009
- Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications. 2006